Clinical Trial Update: Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation [NA]

View source ↗

Summary

The early feasibility study of the Cardiovalve System for tricuspid regurgitation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Snippet

Sponsor: Boston Biomedical Associates | Conditions: Tricuspid Regurgitation | NA | Status: WITHDRAWN